Lexology October 8, 2018
Proskauer Rose LLP

Proskauer and Deloitte convened health care industry leaders to discuss important developments in health care M&A and the regulatory and legislative landscape facing the industry in 2018. These are the seven key takeaways:

1. Powerful forces are driving disruption

The pace and scope of health care deals are only two dimensions of broad-based disruption across the industry. Rapid changes are taking place in the areas of digital health management, consumerism, on-demand pharmacies, retail experiences, greater price transparency and many others.

An even bigger story is how heavyweight investors from outside the health care sector – particularly the unlikely allies of J.P. Morgan, Berkshire Hathaway and Amazon – are making moves to disrupt and reshape the health industry with the aim...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Investments, Mergers & Acquisitions / JV, Payment Models, Population Health Mgmt, Technology, Trends, Value Based
Henry Ford COO looks at shaping culture, operations with Ascension JV
Inside the Justice Department’s Amedisys-Optum Lawsuit
Transactions and Financings: QSL Management Grows Portfolio; BILD and Co. Launches Rebrand
Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec
How Joint Ventures Spark Innovation

Share This Article